Definium Therapeutics, Inc.
DFTX- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001813814
In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Definium Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 174 | 1 | 191 | +18 |
| Shares | 41.5M | 286.3K | 41.2M | −58.8K (−0.1%) |
| Value | $288.9M | $1.99M | $240.5M | −$46.4M (−16.2%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held Definium Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (21)
Institutions that held Definium Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Tri Locum Partners LP | 820,793 | $5.71M |
| Millennium Management LLC | 185,721 | $1.29M |
| Allostery Investments LP | 130,000 | $904.8K |
| BIT Capital GmbH | 63,405 | $441.3K |
| ADAR1 Capital Management, LLC | 25,000 | $174.0K |
| Two Sigma Advisers, LP | 24,650 | $171.6K |
| SG Americas Securities, LLC | 24,406 | $170.0K |
| Corton Capital Inc. | 14,416 | $100.3K |
| Foundations Investment Advisors, LLC | 13,100 | $91.2K |
| SLT Holdings LLC | 13,100 | $91.2K |
| Virtus ETF Advisers LLC | 10,127 | $70.5K |
| Militia Capital Partners, LP | 7,400 | $51.5K |
| Diadema Partners LP | 4,710 | $32.8K |
| Spire Wealth Management | 1,040 | $7.24K |
| Venturi Wealth Management, LLC | 721 | $5.02K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 533 | $3.71K |
| R Squared Ltd | 450 | $3.13K |
| Cornerstone Planning Group LLC | 77 | $531 |
| Kohmann Bosshard Financial Services, LLC | 66 | $459 |
| Glen Eagle Advisors, LLC | 6 | $42 |
| Coppell Advisory Solutions LLC | 1 | $7 |
Not filed for Q1 2025 yet (1)
Institutions that held Definium Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 286,334 | $1.99M |